Ovarian Mucinous Cystadenocarcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Mucinous Cystadenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer [Phase 3]
A Phase 3 trial comparing two first-line regimens (carboplatin-paclitaxel or oxaliplatin-capecitabine) with or without bevacizumab. The stud…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer [NA]
A terminated clinical trial evaluated a triple antiemetic regimen (granisetron, aprepitant, and dexamethasone) to prevent chemotherapy-induc…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for A6 in treating persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary perito…